Apex multiple drug concentration qualitative correction solution - Taiwan Registration edbf49fd5f2609fb043f976c65c6f5b3

Access comprehensive regulatory information for Apex multiple drug concentration qualitative correction solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number edbf49fd5f2609fb043f976c65c6f5b3 and manufactured by MICROGENICS CORPORATION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.